France: Blue Wolf takes next steps in building CDMO platform
Blue Wolf Capital Partners, a middle market private equity firm specializing in the industrial and healthcare sectors, has agreed to acquire Synerlab, a CDMO...
Ireland: Investindustrial agrees acquisition of DCC’s healthcare division for £1.05bn
Healthco Investment (an independently managed investment subsidiary of funds managed and/or advised by Investindustrial Advisors) has agreed to acquire DCC Healthcare, the healthcare division...
Germany: Merck to acquire SpringWorks Therapeutics to accelerate growth of Healthcare business
DAX-listed Merck, a Germany-based global science and technology company, is acquiring Nasdaq-listed SpringWorks Therapeutics, a commercial-stage biopharmaceutical company focused on severe rare diseases and...
Switzerland: Novartis looks to spin off Sandoz business
Swiss-based global healthcare company, Novartis, intends to separate its Sandoz business, a major global player in generic pharmaceuticals and biosimilars, by way of a...
China: Venus Medtech to partner with Haoyue Group on heart implants
Hangzhou-based, transcatheter heart valve company Venus Medtech has set up a joint venture company with Haoyue Group to develop high-end cardiovascular disease implant devices.
Venus...
Germany: Halozyme announces plans to acquire Evotec
US-based Halozyme Therapeutics, a Nasdaq-listed biopharmaceutical company, has made a non-binding proposal to acquire Evotec, a Germany-based publicly listed drug discovery and development company...
Europe: Financing news for Arkhn, AMSilk, SpliSense and Laevoroc Oncology
France: Arkhn, a company that supports healthcare institutions in the management and enhancement of their data, has closed a €4m (US$4.9m) first round of...
Germany: Zentiva secures approximately 85.27% of Apontis Pharma voting rights in public purchase offer
Czech-based Zentiva Pharma has secured approximately 83.57% of the share capital and approximately 85.27% of voting rights in the context of its voluntary public...
The Netherlands: Forbion raises over €2bn across two newest funds
Leading global life sciences venture capital firm, Forbion, has raised over €2bn (US$2.2bn) across its two newest funds, Forbion Growth Opportunities III and Forbion...
Switzerland: Appropriate time for Lonza Group to exit capsules business could be nearing
Bloomberg is reporting that Lonza Group, one of the world’s largest healthcare manufacturing organizations, has appointed Bank of America and Centerview Partners its capsules...
Advertisement
